Exp Clin Endocrinol Diabetes 2010; 118(1): 9-18
DOI: 10.1055/s-0029-1202272
Mini-Review

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Insulinoma in Pregnancy

B. Besemer 1 , K. Müssig 1
  • 1Divison of Endocrinology, Diabetology, Nephrology, Angiology, and Clinical Chemistry, Department of Internal Medicine, University Hospital of Tübingen, Tübingen, Germany
Weitere Informationen

Publikationsverlauf

received 15.08.2008 first decision 23.10.2008

accepted 22.01.2009

Publikationsdatum:
16. April 2009 (online)

Preview

Abstract

Insulinomas are rare, mostly benign neuroendocrine tumours with an incidence of approximately four cases per million person per year. Only isolated case reports of insulinomas occurring in pregnancy have been documented. Clinical signs and symptoms of insulinoma appear to be attenuated and, in some cases, even masked by pregnancy. Therefore, in the present overview of insulinomas occurring during pregnancy, special attention is paid to potential factors contributing to the altered insulin response during pregnancy.

References

Correspondence

Dr. K. MüssigMD 

Medizinische Klinik IV

Universitätsklinikum Tübingen

Otfried-Müller-Str. 10

72076 Tübingen

Germany

Telefon: +49/0/7071/29 836 70

Fax: +49/0/7071/29 27 84

eMail: Karsten.Muessig@med.uni-tuebingen.de